Thermo Fisher: With A 30% Price Drop, Trump Legislation, And High Capex, Is It Undervalued?

Group 1 - The company Thermo Fisher (NYSE: TMO) has been successful in investing significant financial resources to expand its operations, dedicating an average of 16.51% of its revenues to capital expenditures [1] Group 2 - The analyst Daniel Mellado has a background in economics and statistics, with experience in analyzing agricultural commodities and managing trading and data analysis teams [1] - The trading team managed by the analyst invested in bonds, equities, and ETFs, indicating a diverse investment strategy [1] - The analyst's future contributions will focus on analysis and valuation for companies in sectors such as commodities, banking, technology, and pharmaceuticals [1]